Pro/con debate: Is etomidate safe in hemodynamically unstable critically ill patients?

Gordon Flynn, Yahya Shehabi

Research output: Contribution to journalReview ArticleOtherpeer-review

17 Citations (Scopus)


Etomidate is an induction agent known for its smooth intubating conditions and cardiovascular stability. Studies, however, have shown that a single dose of etomidate can result in a prolonged adrenal insufficiency. The impact of this in patients with sepsis has been a matter for debate. This review presents a pro/con case for using etomidate in hemodynamically unstable critically ill patients and provides guidance for alternative induction techniques and when the use of etomidate might be justified despite these concerns.

Original languageEnglish
Pages (from-to)227
Number of pages1
JournalCritical Care
Issue number4
Publication statusPublished - 2012

Cite this